-
Company Insights
Human Longevity, Inc. – Tech Innovator Profile
Human Longevity, Inc. (HLI) is a genomic-driven health intelligence company that combines DNA sequencing and analysis with machine learning (ML). With a team of research scientists, computing experts, and physicians, HLI developed a database of sequenced genomes and phenotypic (physical traits) data to derive meaningful insights and make discoveries for better personal health plans and new treatment options.
-
Product Insights
Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscular Dystrophy Pipeline Drugs Market Report Overview Muscular dystrophy is a group of diseases in which muscle fibers are unusually susceptible to damage. These damaged muscles become progressively weaker. Symptoms usually appear before age 6 and may appear as early as infancy. They may include fatigue, learning difficulties, intellectual disability, muscle weakness, and progressive difficulty walking. The report titled ‘Muscular Dystrophy –Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update’, provides an overview of...
-
Product Insights
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 33 molecules. Out of which approximately 30 molecules are developed by companies and remaining by the universities/institutes. The latest report Gastric Inhibitory Polypeptide Receptor – Drugs In Development, 2022, outlays comprehensive information on the Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and...
-
Company Insights
Human Longevity, Inc. – Tech Innovator Profile
Human Longevity, Inc. (HLI) is a genomic-based health intelligence company that combines DNA sequencing and analysis with machine learning (ML).
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
-
Company Insights
Company Profile: Human Longevity, Inc.
Human Longevity, Inc. (HLI) is a genomic-based health intelligence company that combines state-of-the-art DNA sequencing and expert analysis with machine learning (ML).
-
Sector Analysis
Japan Diagnostic Imaging Market Outlook to 2025 – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems and Others
GlobalData’s “Japan Diagnostic Imaging Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Japan Diagnostic Imaging market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems. The Japan Diagnostic Imaging Market report provides key information and data on: • Annualized market revenues (USD), volume...